Isotope-labeled ADC Related Products

Introduction

Antibody–drug conjugates (ADCs) have become an important class of targeted therapeutics, particularly in oncology. By combining the selectivity of monoclonal antibodies with the strong cytotoxic activity of small-molecule drugs, ADCs can selectively deliver highly potent payloads to tumor cells while reducing systemic toxicity. As ADC drug development continues to expand, stable isotope-labeled ADC-related compounds have become essential analytical tools for pharmacokinetic studies, bioanalysis, and drug development.

What are Antibody–Drug Conjugates (ADCs)?

ADCs are targeted biopharmaceuticals composed of three key components: a monoclonal antibody that recognizes a tumor-associated antigen, a highly potent cytotoxic payload capable of killing cancer cells at very low concentrations, and a chemical linker that connects the payload to the antibody and controls its release. After binding to specific antigens on tumor cells, the ADC are internalized, and the linker is cleaved or degraded within the cell to release the cytotoxic drug, ultimately inducing tumor cell death. This targeted delivery mechanism allows ADCs to combine the specificity of biologics with the strong anticancer activity of small-molecule drugs, making them an important strategy in modern cancer therapy.

Fig. 1. The components of ADCs.

The Importance of Isotope-Labeled Products in ADCs

The quantitative analysis of ADC cytotoxic payloads and their metabolites in biological samples is a critical step in the development of ADC drugs. Accurate measurement of these compounds in blood or other biological matrices provides essential information about pharmacokinetics, biodistribution, and metabolism, which are crucial for evaluating drug safety, efficacy, and dosing strategies. Because ADC payloads are often extremely potent and present at very low concentrations in vivo, highly sensitive and reliable analytical methods are required.

Because isotope-labeled compounds have nearly identical chemical and physical properties to their unlabeled counterparts, they exhibit the same chromatographic behavior and ionization efficiency during LC–MS analysis. This allows stable isotope-labeled versions (such as deuterium- or 13C-labeled analogs) to serve as ideal internal standards for quantitative bioanalysis of ADC cytotoxic payloads. And they can eliminate matrix interference and significantly improve detection accuracy and sensitivity. Moreover, with the advancement of mass spectrometry technology, LC–MS methods can now be used to characterize and quantify both small molecules and complex biomolecules, making isotope-labeled ADC payloads and related compounds indispensable tools in ADC pharmacokinetic studies, bioanalytical method development, and new drug research.

What We Offer

To support the growing demand for high-quality analytical standards in ADC research, Alfa Chemistry provides a comprehensive portfolio of isotope-labeled ADC-related products, including payloads, linkers, and drug-linker conjugates. These products are designed to facilitate bioanalytical method development, pharmacokinetic studies, and metabolism research.

• Isotope-Labeled ADC Payloads

We provide high-quality stable isotope-labeled versions of commonly used ADC payloads, incorporating isotopes such as deuterium, carbon-13, or nitrogen-15. These labeled payloads retain the same physicochemical properties as their native counterparts, making them ideal internal standards for LC–MS/MS quantitative analysis in pharmacokinetic, metabolism, and bioanalytical studies.

• Isotope-Labeled ADC Linkers

The chemical linker is a crucial structural component that determines the stability of the ADC in circulation and the controlled release of the payload within target cells. To support studies on linker stability and degradation pathways, we offer isotope-labeled ADC linkers that enable researchers to track linker-related metabolites and degradation products during in vitro and in vivo studies. These labeled linkers can help improve the understanding of ADC drug metabolism and provide valuable insights for optimizing linker design in next-generation ADC therapeutics.

• Isotope-Labeled Drug-Linker Conjugates for ADC

Drug-linker conjugates represent important intermediates in ADC construction and are also key analytes generated during ADC metabolism. Our isotope-labeled drug-linker conjugates are designed to support quantitative LC–MS analysis and bioanalytical method development by serving as accurate reference standards. They are particularly useful for studying ADC stability, metabolism, and pharmacokinetics in complex biological systems.

Online Inquiry



mg g kg ml L

Isotope-labeled ADC Related Products

SUBMIT